Provided by Tiger Trade Technology Pte. Ltd.

Merck

143.93
-0.7800-0.54%
Post-market: 144.010.0800+0.06%19:57 EDT
Volume:8.68M
Turnover:1.25B
Market Cap:355.10B
PE:113.08
High:145.90
Open:145.52
Low:143.68
Close:144.71
52wk High:156.92
52wk Low:77.58
Shares:2.47B
Float Shares:2.47B
Volume Ratio:1.14
T/O Rate:0.35%
Dividend:3.36
Dividend Rate:2.33%
EPS(TTM):1.27
EPS(LYR):7.28
ROE:6.96%
ROA:11.87%
PB:8.47
PE(LYR):19.77

Loading ...

Summit Therapeutics Says it is Beating Merck with Its Cancer Drug

Dow Jones
·
Sep 04

Jefferies Reaffirms Their Hold Rating on Merck KGaA (0O14)

TIPRANKS
·
Sep 03

Novartis Signs Deal Worth up to $3.2 Billion for Alteogen's Drug Delivery Technology

Reuters
·
Sep 02

Merck CFO Litchfield, R&D Chief Li to Speak at Wells Fargo Healthcare Conference

Reuters
·
Sep 02

Movement Alert|Merck Rises 3.65% in Pre-Market Trading, HSBC Upgrades to Buy as mRNA Cancer Vaccine Momentum Continues

Market Focus
·
Sep 02

Merck (MRK) Wins FDA Approval For First Oral PCSK9 Cholesterol Drug

Simply Wall St.
·
Sep 02

Merck Files Form 3 for EVP, CIDO Gaurav Gupta

Reuters
·
Sep 02

Rpt: Who: Ervebo Should Only be Used for Bundibugyo Virus (Bvdv) Within the Context of a Research Protocol at This Time

THOMSON REUTERS
·
Sep 01

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

Moderna Led the S&P 500 in August as Edison International Sank

Dow Jones
·
Sep 01

Pharma Industry Stares Down Biggest Patent Cliff in Decades

Dow Jones
·
Aug 29

Success After a Century of Failures: Inside Moderna and Merck's Cancer Vaccine Breakthrough

Reuters
·
Aug 28

RBC Capital Reaffirms Their Hold Rating on Merck & Company (MRK)

TIPRANKS
·
Aug 27

Nike, Merck Share Losses Contribute to Dow's 150-Point Drop

Dow Jones
·
Aug 26

Merck & Co. Inc. Stock Rises 3.8%, Outperforms Peers

Dow Jones
·
Aug 26

Dow up 136 Points on Gains for Shares of Merck, Goldman Sachs

Dow Jones
·
Aug 26

Merck & Co Inc Stock (MRK) Moved Up by 3.76% on Aug 25: A Full Analysis

TradingKey
·
Aug 26

Movement Alert|Merck Rises 3.06% in Regular Trading, Multiple Analyst Upgrades Continue to Boost Shares Following mRNA Cancer Vaccine Phase III Success

Market Focus
·
Aug 26

Moderna Stock (MRNA) Rises 12.5% Today Following Phase 3 mRNA Cancer Vaccine Win with Merck

TIPRANKS
·
Aug 26

Merck Price Target Raised to $170.00/Share from $145.00 by Argus Research

Dow Jones
·
Aug 25